Showing results (1291-1300 of 1,714) with videos related to

Sort By:
Pageof 172
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2009
Differential use of CARD9 by dectin-1 in macrophages and dendritic cellsHelen S Goodridge, Takahiro Shimada, Andrea J Wolf, et al.
Human Reproduction (Oxford, England)|May 1, 1991
Quality of oocytes from superovulated rhesus monkeysL D Johnson, B A Mattson, D F Albertini, et al.
Medical and Pediatric Oncology|March 1, 1997
Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patientsF J Barriga, M Varas, M Potin, et al.
Epilepsy & Behavior Case Reports|January 6, 2017
A major miss in prognostication after cardiac arrest: Burst suppression and brain healingDanielle A Becker, Nicholas D Schiff, Lance B Becker, et al.
Frontiers in Immunology|June 20, 2019
T Cell-Specific Overexpression of Acid Sphingomyelinase Results in Elevated T Cell Activation and Reduced Parasitemia During Plasmodium yoelii InfectionMatthias Hose, Anne Günther, Hanna Abberger, et al.
Biophysical Journal|October 22, 2020
Characterization of Gene Repression by Designed Transcription Activator-like Effector Dimer ProteinsNicole A Becker, Justin P Peters, Tanya L Schwab, et al.
ACS Nano|November 11, 2020
Unraveling the Origin of the Long Fluorescence Decay Component of Cesium Lead Halide Perovskite NanocrystalsMichael A Becker, Caterina Bernasconi, Maryna I Bodnarchuk, et al.
International Journal of Exercise Science|January 9, 2023
The Association of Field Test Outcomes with Peak Oxygen Uptake in Patients with Cystic Fibrosis: A Systematic ReviewNatália E Campos, Fernanda M Vendrusculo, Gisele A DA Costa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 27, 2016
Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study)Kenneth G Saag, David Fitz-Patrick, Jeff Kopicko, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2011
Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatmentA Becker, L Crombag, D A M Heideman, et al.
Pageof 172